Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

1.1K
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.1K
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

1.0K
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
1.0K
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

541
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
541
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

632
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
632
Basic Concept01:28

Basic Concept

6.2K
Engineering mechanics is a branch of engineering that studies motion and the forces acting on objects. It is a fundamental subject and forms the basis of many other engineering disciplines. Length, time, mass, and force are some basic concepts in engineering mechanics.
Length, which measures the distance traveled by an object, is a fundamental concept in engineering mechanics. We use coordinates relative to a reference point to describe the distance. Length not only helps to describe the...
6.2K
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

755
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
755

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A standardized fecal microbiota transplantation protocol enables consistent, microbiota-driven colitis in IL-10-deficient mice.

Frontiers in microbiology·2026
Same author

Integrin β7 sustains ileal humoral immunity and microbial biogeography during chronic TNF-driven ileitis.

Mucosal immunology·2026
Same author

Expert consensus on passive heating interventions to promote skeletal muscle strength and mass: a delphi study.

European journal of applied physiology·2026
Same author

Effect of body mass on physiological and time-trial performance responses to mixed-method cooling applied between exercise bouts in the heat.

Frontiers in physiology·2026
Same author

Outcomes of Difficult-to-Treat Ulcerative Colitis: Impact of Primary Nonresponse vs Secondary Loss of Response to Prior Therapies: A Retrospective Cohort Study.

Gastro hep advances·2026
Same author

A stromal-state dichotomy governs recalcitrance or remission in inflammatory bowel disease.

bioRxiv : the preprint server for biology·2026

Related Experiment Video

Updated: Feb 5, 2026

Dynamic Adhesion Assay for the Functional Analysis of Anti-adhesion Therapies in Inflammatory Bowel Disease
08:27

Dynamic Adhesion Assay for the Functional Analysis of Anti-adhesion Therapies in Inflammatory Bowel Disease

Published on: September 20, 2018

8.1K

Cell Trafficking Interference in Inflammatory Bowel Disease: Therapeutic Interventions Based on Basic Pathogenesis

Tamara Pérez-Jeldres1,2,3, Christopher J Tyler1,4, Joshua D Boyer1,4

  • 1Inflammatory Bowel Disease Center, Division of Gastroenterology, University of California San Diego, La Jolla, CA, USA.

Inflammatory Bowel Diseases
|August 31, 2018
PubMed
Summary
This summary is machine-generated.

Targeting leukocyte trafficking offers a new therapeutic approach for inflammatory bowel disease (IBD), moving beyond cytokine blockade. This strategy involves blocking molecules essential for immune cell movement, showing promise in clinical trials for IBD treatment.

More Related Videos

DNBS/TNBS Colitis Models: Providing Insights Into Inflammatory Bowel Disease and Effects of Dietary Fat
09:04

DNBS/TNBS Colitis Models: Providing Insights Into Inflammatory Bowel Disease and Effects of Dietary Fat

Published on: February 27, 2014

49.0K
Ultrasound-guided Intracardiac Injection of Human Mesenchymal Stem Cells to Increase Homing to the Intestine for Use in Murine Models of Experimental Inflammatory Bowel Diseases
07:45

Ultrasound-guided Intracardiac Injection of Human Mesenchymal Stem Cells to Increase Homing to the Intestine for Use in Murine Models of Experimental Inflammatory Bowel Diseases

Published on: September 1, 2017

12.7K

Related Experiment Videos

Last Updated: Feb 5, 2026

Dynamic Adhesion Assay for the Functional Analysis of Anti-adhesion Therapies in Inflammatory Bowel Disease
08:27

Dynamic Adhesion Assay for the Functional Analysis of Anti-adhesion Therapies in Inflammatory Bowel Disease

Published on: September 20, 2018

8.1K
DNBS/TNBS Colitis Models: Providing Insights Into Inflammatory Bowel Disease and Effects of Dietary Fat
09:04

DNBS/TNBS Colitis Models: Providing Insights Into Inflammatory Bowel Disease and Effects of Dietary Fat

Published on: February 27, 2014

49.0K
Ultrasound-guided Intracardiac Injection of Human Mesenchymal Stem Cells to Increase Homing to the Intestine for Use in Murine Models of Experimental Inflammatory Bowel Diseases
07:45

Ultrasound-guided Intracardiac Injection of Human Mesenchymal Stem Cells to Increase Homing to the Intestine for Use in Murine Models of Experimental Inflammatory Bowel Diseases

Published on: September 1, 2017

12.7K

Area of Science:

  • Gastroenterology
  • Immunology
  • Pharmacology

Background:

  • Targeting pro-inflammatory cytokines has been the standard for inflammatory bowel disease (IBD) treatment for two decades.
  • Advances in understanding IBD pathogenesis have revealed leukocyte trafficking as a key therapeutic target.

Purpose of the Study:

  • To review the emerging therapeutic strategy of targeting leukocyte trafficking molecules for IBD treatment.
  • To discuss current and future therapeutic targets and approaches in modulating immune cell traffic for IBD.

Main Methods:

  • Review of clinical trial data for drugs targeting leukocyte trafficking molecules in IBD.
  • Discussion of various molecular targets including chemokines, receptors, integrins, and their ligands.
  • Exploration of strategies interfering with lymphocyte recirculation and novel delivery systems.

Main Results:

  • Two drugs (natalizumab, vedolizumab) targeting leukocyte trafficking are approved for IBD.
  • Several other agents targeting chemokines, integrins, and endothelial ligands are in late-stage clinical trials.
  • Small molecule sphingosine-phosphate receptor (S1PR) agonists represent a distinct strategy for lymphocyte recirculation modulation.

Conclusions:

  • Blockade of leukocyte trafficking molecules represents a new therapeutic era for IBD.
  • Future strategies include novel small molecules, allosteric inhibitors, and nanovector-based RNA interference.
  • Modulating pro-inflammatory leukocyte trafficking holds significant potential for improved IBD management.